Trial Profile
Phase I trial of lebrikizumab in Japan.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2011
Price :
$35
*
At a glance
- Drugs Lebrikizumab (Primary)
- Indications Asthma
- Focus Adverse reactions
- 06 Sep 2011 New trial record